Decker Wealth Management LLC Takes Position in HCA Healthcare, Inc. $HCA

Key Points

• Decker Wealth Management LLC opened a new position in HCA Healthcare during the first quarter, buying 14,259 shares worth about $6.75 million. The stake represents roughly 1.5% of its portfolio.
• HCA Healthcare recently reported quarterly EPS of $7.15, missing estimates by a small margin, while revenue came in at $19.11 billion, slightly above expectations and up 4.3% year over year.
• Analysts remain broadly constructive on the stock, with 14 Buy ratings, 9 Hold ratings, and a consensus price target of about $486.14. The company also pays a quarterly dividend of $0.78 per share, equal to a 0.8% yield.

Decker Wealth Management LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,259 shares of the company's stock, valued at approximately $6,748,000. HCA Healthcare makes up approximately 1.5% of Decker Wealth Management LLC's portfolio, making the stock its 26th largest position.

Other large investors also recently modified their holdings of the company. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the 3rd quarter valued at $26,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter worth about $31,000. Cedar Mountain Advisors LLC bought a new position in HCA Healthcare in the 1st quarter valued at about $33,000. JPL Wealth Management LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $33,000. Finally, Aventura Private Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $34,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE HCA opened at $371.60 on Monday. The company has a market capitalization of $82.44 billion, a PE ratio of 12.78, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company has a 50-day simple moving average of $392.25 and a 200 day simple moving average of $456.93.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the prior year, the company earned $6.45 earnings per share. The firm's revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 29.73 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare's dividend payout ratio is currently 10.73%.

Analyst Ratings Changes

A number of research firms recently commented on HCA. Argus lowered their price target on HCA Healthcare from $560.00 to $500.00 and set a "buy" rating for the company in a research report on Monday, May 4th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a report on Tuesday, July 7th. Oppenheimer cut their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an "outperform" rating on the stock in a report on Monday, April 27th. Truist Financial set a $413.00 target price on shares of HCA Healthcare in a research report on Thursday, June 4th. Finally, TD Cowen reduced their target price on HCA Healthcare from $500.00 to $431.00 and set a "buy" rating for the company in a report on Monday, June 22nd. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $486.14.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.